RxDoctor Payments Data

Christopher Sipe

Reproductive Endocrinology · Glenview, ILNPI 1184767725

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,161 of the $5,200 with a category attached, or 60.8%. Ferring Pharmaceuticals Inc. accounts for 65.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $2,004 and has fallen 77.1% since, to $459 in 2025.

$5,200in general payments, 2019–2025

Across 177 payments — averaging $29.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$3K
  • Organon$876
  • Merck$295
  • EMD Serono, Inc.$198
  • Coopersurgical, Inc.$121
  • AbbVie$118
  • plus $201 from 6 others

What the payments were for

  • Consulting fees$1,74834%
  • Food & beverage$3,16161%
  • Education$2916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,200 in reported general payments places this provider in the 80th percentile of 62 reproductive endocrinology providers in Illinois.

See all reproductive endocrinology providers in Illinois

Other reproductive endocrinology in Glenview

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →